Register entry

BIPSO GmbH

Data as of · How to read this entry

Registered sites
0
Active NDC listings
7
Live patents
0
Countries
0
Catalogue

Drug listings by form and route

7

7 active NDC listings: 7 human prescription drug. By marketing category: UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE 7.

Dosage formNDCs
injection, solution7
RouteNDCs
intravascular7
Labeller name on the listingNDCs
bipso gmbh7
Catalogue

Marketed products

7
BrandGeneric nameForm / routeNDC
IomeronIomeprol Injectioninjection, solution, intravascular76381-725UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
IomeronIomeprol Injectioninjection, solution, intravascular76381-730UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
IomeronIomeprol Injectioninjection, solution, intravascular76381-735UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
IomeronIomeprol Injectioninjection, solution, intravascular76381-740UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
IomeronIomeprol Injectioninjection, solution, intravascular76381-930UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
IomeronIomeprol Injectioninjection, solution, intravascular76381-935UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
IomeronIomeprol Injectioninjection, solution, intravascular76381-940UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE
Compare

Other companies listing iomeprol injection

Enquiry

Common questions

Is BIPSO GmbH FDA approved?
BIPSO GmbH holds no registered establishment of its own; 7 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does BIPSO GmbH make?
7 products are listed under BIPSO GmbH in the openFDA NDC Directory, most often as injection, solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.